Funder: ALS Association
Due Dates (Anticipated): June 2026: Letter of Intent deadline (projected) | August 2026: Full proposal deadline (by invitation only) (projected)
Funding Amounts: Up to $400,000 total (direct + indirect) over 4 years; indirect costs capped at 10% of direct costs.
Summary: Supports U.S. clinical trial sites in expanding ALS trial capacity and participant diversity, focusing on infrastructure and access for underserved populations.